medigraphic.com
ISSN 1561-3119 (Electronic)

2012, Number 1

<< Back Next >>

Rev Cubana Pediatr 2012; 84 (1)

Characterization of obese children and adolescents with metabolic syndrome

Santiago MY, Miguel SPE, Ricardo SA, Marrero HMM, Peña PI

Language: Spanish
References: 33
Page: 11-21
PDF size: 99.89 Kb.


ABSTRACT

Introduction: the metabolic syndrome is more frequent in children and adolescents with obesity.
Objective: to determine some clinical, anthropometry and laboratory features in obese children with metabolic syndrome.
Methods: a cross-sectional study was conducted in 59 obese children and adolescents aged between 2 and 14, selected by randomized sampling of 20 consulting rooms from the "Urbano Noris" municipality, Holguín province seen in April-May, 2010. Variables included: sex, age, weight, height, body mass index (BMI), abdominal circumference, blood pressure, total cholesterol, triglycerides, glycemia, HDL-cholesterol, LDLcholesterol, microalbuminuria and the total cholesterol rates/HDL-cholesterol and LDLcholesterol/ HDL-cholesterol, as well as the presence of a high blood pressure and diabetes mellitus. Variance analysis was used and also the χ2 test in SPSS and the significance level of 0.05. Screening was carried out according to the Cuban criteria based on the National Program of Education on the Cholesterol of United States.
Results: the frequency of metabolic syndrome was of 55.9 %. These ones had high values of blood pressure, triglycerides, glycemia, LDL-cholesterol and the atherogenic rates and concentrations of high-density lipoproteins lower than the group without metabolic syndrome (n= 26). There was a significant association between the metabolic syndrome and the high blood pressure, but not with the microalbuminuria and diabetes mellitus. There were not gender differences.
Conclusions: the diagnosis of the metabolic syndrome is very important in children and adolescents to a better characterization of this stage and it is recommended an intervention based on the changes in the lifestyles.


REFERENCES

  1. Hernández Tamayo M, Miguel Soca PE, Marrero Hidalgo MM, Pérez López LM, Peña Pérez I, Rivas Estévez M. Comportamiento de variables clínicas, antropométricas y de laboratorio en pacientes con síndrome metabólico. Medisur [serie en internet]. 2011 [citado 5 de junio de 2011];9(2). Disponible en: http://www.medisur.sld.cu/index.php/medisur/article/view/1260/716

  2. Zimmet P, Alberti K, George MM, Kaufman F, Tajima N, Silink M, et al. The metabolic syndrome in children and adolescents-an IDF consensus report. Pediatr Diabetes. 2007;8:299-306.

  3. Brufani C, Grossi A, Fintini D, Fiori R, Ubertini G, Colabianchi D, et al. Cardiovascular Fitness, Insulin Resistance and Metabolic Syndrome in Severely Obese Prepubertal Italian Children. Horm Res. 2008;70:349-56.

  4. Cali AMG, Caprio S. Ectopic Fat Deposition and the Metabolic Syndrome in Obese Children and Adolescents. Horm Res. 2009;71(suppl 1):2-7.

  5. Dimitrijevic-Sreckovic V, Colak E, Djordjevic P, Gostiljac D, Sreckovic B, Popovic S, et al. Prothrombogenic factors and reduced antioxidative defense in children and adolescents with pre-metabolic and metabolic síndrome. Clin Chem Lab Med. 2007;45(9):1140-4.

  6. Miguel Soca PE, Niño Escofet S, Rodríquez López M, Almaguer Herrera A. Pesquisaje de síndrome metabólico en mujeres obesas. Revista Cocmed [serie en internet]. 2004 [citado 3 de junio de 2011];8(4). Disponible en: http://www.cocmed.sld.cu/no84/n84ori5.htm

  7. Savino A, Pelliccia P, Chiarelli F, Mohn A. Obesity-Related Renal Injury in Childhood. Horm Res Paediatr. 2010;73:303-11.

  8. Burt Solorzano CM, McCartney CR. Obesity and the pubertal transition in girls and boys. Reproduction. 2010;140(3):399-410.

  9. Carranza Madrigal J, López Correa SM. El síndrome metabólico en México. Med Int Mex. 2008;24(4):251-61.

  10. Oquendo de la Cruz Y, Piñeiro Lamas R, Duarte MC, Guillen Dosal A. Síndrome metabólico en niños y adolescentes hipertensos obesos. Rev Cubana Pediatr. 2010;82(4):31-40.

  11. Ilanne-Parikka P, Eriksson JG, Linstrom J, Hamalainen H, Keinanen-Kiukaanniemi S, Laakso M, et al. Prevalence of the Metabolic Syndrome and its Components. Findings from a Finnish general population sample and the Diabetes Prevention Study Cohort. Diabetes Care. 2004;27(9):2135-40.

  12. Comisión Nacional Técnica Asesora del Programa de Hipertensión Arterial. Hipertensión arterial. Guía para la prevención, diagnóstico y tratamiento. La Habana: Editorial Ciencias Médicas;2008.

  13. Ocampo Segura A, Hernández Rodríguez YA, Figueiras Ramos B, López Fernández R, Benet Rodríguez M. Alteraciones plurimetabólicas y factores de riesgo cardiovasculares asociados a la hipertensión en la comunidad. Medisur [serie en internet]. 2004 [citado 28 de mayo de 2011];2(1). Disponible en: http://www.medisur.sld.cu/index.php/medisur/article/view/36/4573

  14. Benet Rodríguez M, Cabrera Núñez RM, Castillo Sardiñas P, Poll Cañizares Y, Suárez Y. Prevalencia de síndrome metabólico en los trabajadores de la Facultad de Ciencias Médicas de Cienfuegos. Medisur [serie en internet]. 2005 [citado 15 de abril de 2011];3(2). Disponible en: http://www.medisur.sld.cu/index.php/medisur/article/view/104

  15. Miguel Soca P, Cruz Torres W, González Ferrer J, Cardona Cáceres X, Cruz Lage LA, Hernández Tamayo M. Efectos beneficiosos de cambios en la dieta y ejercicios físicos en mujeres obesas con síndrome metabólico. Revista Panorama Cuba y Salud. 2009;4(3):29-36.

  16. Calderín Bouza RO, Prieto Valdés M, Cabrera Rode E. Síndrome de insulinorresistencia en niños y adolescentes. Rev Cubana Endocrinol [serie en internet]. 2007 [citado 12 de abril de 2011];18(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532007000200007&lng=es&nrm=iso&tlng=es

  17. De la Torre Montejo E, Pelayo González-Posada EJ. Pediatría. Tomo I. La Habana: Editorial Ciencias Médicas; 2006. p. 264-74.

  18. Argote Parolis J, Fernández Terue T, Carvajal Martínez F, González Suárez RM, Licea Puig ME. Prevalencia y factores asociados al síndrome metabólico en niños y adolescentes obesos del municipio Marianao. Rev Cubana Endocrinol [serie en internet]. 2008 [citado 15 de mayo de 2011];19(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532008000300002&lng=es&nrm=iso&tlng=es

  19. Hirschler V, Calcagno ML, Aranda C, Maccallini G, Jadzinsky M. Can the metabolic syndrome identify children with insulin resistance? Pediatr Diabetes. 2007;8:272-7.

  20. Dhuper S, Cohen HW, Daniel J, Gumidyala P, Agarwalla V, St Victor R, et al. Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study. Cardiovasc Diabetol [serie en internet]. 2007 [citado 15 de junio de 2011];6(4). Disponible en: http://www.cardiab.com/content/6/1/4

  21. Calcaterra V, Klersy C, Muratori T, Telli S, Caramagna C, Scaglia F. Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity. Clin Endocrinol. 2008;68:868-72.

  22. Clavijo Z. Aspectos relativos a la relación existente entre la obesidad y la hipertensión. Int J Med Sci Phys Educ Sport. 2009;5(1):49-58.

  23. Francischetti EA, Celoria BMJ, Francischetti A, Genelhu VA. Treatment of hypertension in individuals with the cardiometabolic syndrome: role of an angiotensin II receptor blocker, telmisartan. Expert Rev Cardiovasc Ther. 2008;6(3):289-303.

  24. Ibrahim MM. RAS inhibition in hypertension. J Hum Hypertens. 2006;20:101-8.

  25. Giles TD, Sander GE. Pathophysiologic, Diagnostic, and Therapeutic Aspects of the Metabolic Syndrome. J Clin Hypertens. 2005;7:669-78.

  26. Nelson RA, Bremer AA. Insulin Resistance and Metabolic Syndrome in the Pediatric Population. Met Syndr Relat Disord. 2010;8(1):1-14.

  27. Miguel Soca PE. El síndrome metabólico: un alto riesgo para individuos sedentarios. Acimed [serie en internet]. 2009 [citado 10 de mayo de 2011];20(2). Disponible en: http://scielo.sld.cu/pdf/aci/v20n2/aci07809.pdf

  28. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest. 2008;118:2992-3002.

  29. Miguel Soca PE. Dislipidemias. Acimed. 2009;20(6):265-73.

  30. Andrade H, Antonio N, Rodrigues D, Marinho Da Silva A, Pêgo M, Providencia LA. Hipertensão arterial sistémica em idade pediátrica. Rev Port Cardiol. 2010;29(03):413-32.

  31. Ebrahimpour P, Fakhrzadeh H, Pourebrahim R, Hamidi A, Larijani B. Metabolic Syndrome and Related Insulin Levels in Obese Children. Met Syndr Relat Disord. 2006;4(3):172-8.

  32. Chang Y, Yoo T, Ryu S, Huh BY, Cho BL, Sung E, et al. Abdominal obesity, systolic blood pressure, and microalbuminuria in normotensive and euglycemic Korean men. Int J Obes. 2006;30:800-4.

  33. Liese AD, Hense HW, Doring A, Stieber J, Keil U. Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey1994/95. J Hum Hypertens. 2001;15:799-804.




2020     |     www.medigraphic.com